St. Anthony Residency Communicaiton

Hi All, Here are the September clinic updates: 144 th has an iSTAT machine for the convenience care clinic—it can run a CBC and a BMP (not a CMP like I said before) in just a few minutes if you want to use it instead of STAT labs through LabCorp. New urine drug screens are available called ToxAssure—see attached document for their testing capacity. Flu shots are here—give them to your patients and get one for yourself. Vaccine change—we’re changing vaccine vendors so work with your MA and double check your vaccine orders to make sure you’re using the correct combo vaccines. You might see “Amazon” on your reason for visit—this just means the patient responded to a marketing flyer they received in the mail. LEARN module: Corporate Responsibility 2018 due by Sept 30 th —do it! On October 1 st —we’re going to start sending all pathology (paps, biopsies, etc.) to LabCorp instead of MetroPath —there will be separate email detailing how to do this later. ...

Dear faculty, staff, partners,   As a team we have chosen to introduce Medication Assisted Treatment into our clinics. This decision was made in response to the increased number of deaths we have seen in our patients suffering from opiate use disorder in Colorado.  We feel it is essential for us to provide patients with an opportunity to survive living with this disorder.  As a result, we will be offering Medication Assisted treatment in the form of suboxone inductions, group visits for patients on a stable dose of suboxone, Behavioral health support for patients suffering from opiate use disorder, and help with transitions to higher level care at Behavioral Health Group or Community Reach (when needed).    Our first induction will be scheduled on September 10 th . We are hoping to schedule one induction (start of suboxone treatment) every Monday afternoon over the next few weeks.  Any patient interested in induction must have a visit for a ...

Clinic, inpatient and residency updates go here ***************************************************************************** This communication is for the use of the intended recipient only. It may contain information that is privileged and confidential. If you are not the intended recipient of this communication, any disclosure, copying, further distribution or use thereof is prohibited. If you have received this communication in error, please advise me by return e-mail or by telephone and delete/destroy it. *****************************************************************************